• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SIO:一种用于识别与卵巢肿瘤微环境相关的预后生物标志物的空间影像组学流程。

SIO: A Spatioimageomics Pipeline to Identify Prognostic Biomarkers Associated with the Ovarian Tumor Microenvironment.

作者信息

Zhu Ying, Ferri-Borgogno Sammy, Sheng Jianting, Yeung Tsz-Lun, Burks Jared K, Cappello Paola, Jazaeri Amir A, Kim Jae-Hoon, Han Gwan Hee, Birrer Michael J, Mok Samuel C, Wong Stephen T C

机构信息

Center for Modeling Cancer Development, Houston Methodist Cancer Center, Houston Methodist Hospital, Houston, TX 77030, USA.

Departments of Pathology and Laboratory Medicine and Radiology, Houston Methodist Hospital, Weill Cornell Medicine, Houston, TX 77030, USA.

出版信息

Cancers (Basel). 2021 Apr 8;13(8):1777. doi: 10.3390/cancers13081777.

DOI:10.3390/cancers13081777
PMID:33917869
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8068305/
Abstract

Stromal and immune cells in the tumor microenvironment (TME) have been shown to directly affect high-grade serous ovarian cancer (HGSC) malignant phenotypes, however, how these cells interact to influence HGSC patients' survival remains largely unknown. To investigate the cell-cell communication in such a complex TME, we developed a SpatioImageOmics (SIO) pipeline that combines imaging mass cytometry (IMC), location-specific transcriptomics, and deep learning to identify the distribution of various stromal, tumor and immune cells as well as their spatial relationship in TME. The SIO pipeline automatically and accurately segments cells and extracts salient cellular features to identify biomarkers, and multiple nearest-neighbor interactions among tumor, immune, and stromal cells that coordinate to influence overall survival rates in HGSC patients. In addition, SIO integrates IMC data with microdissected tumor and stromal transcriptomes from the same patients to identify novel signaling networks, which would lead to the discovery of novel survival rate-modulating mechanisms in HGSC patients.

摘要

肿瘤微环境(TME)中的基质细胞和免疫细胞已被证明可直接影响高级别浆液性卵巢癌(HGSC)的恶性表型,然而,这些细胞如何相互作用以影响HGSC患者的生存情况在很大程度上仍不清楚。为了研究如此复杂的TME中的细胞间通讯,我们开发了一种空间图像组学(SIO)流程,该流程结合了成像质谱流式细胞术(IMC)、定位特异性转录组学和深度学习,以识别各种基质细胞、肿瘤细胞和免疫细胞在TME中的分布及其空间关系。SIO流程可自动且准确地分割细胞并提取显著的细胞特征以识别生物标志物,以及肿瘤细胞、免疫细胞和基质细胞之间的多个最近邻相互作用,这些相互作用共同影响HGSC患者的总体生存率。此外,SIO将IMC数据与来自同一患者的显微切割肿瘤和基质转录组整合,以识别新的信号网络,这将有助于发现HGSC患者新的生存率调节机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43f8/8068305/f9127b773c08/cancers-13-01777-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43f8/8068305/f85514502dfa/cancers-13-01777-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43f8/8068305/1a33228287f2/cancers-13-01777-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43f8/8068305/8f9435979509/cancers-13-01777-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43f8/8068305/4e7db5861dd2/cancers-13-01777-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43f8/8068305/3e1ff12b9780/cancers-13-01777-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43f8/8068305/95ec15d31837/cancers-13-01777-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43f8/8068305/f9127b773c08/cancers-13-01777-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43f8/8068305/f85514502dfa/cancers-13-01777-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43f8/8068305/1a33228287f2/cancers-13-01777-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43f8/8068305/8f9435979509/cancers-13-01777-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43f8/8068305/4e7db5861dd2/cancers-13-01777-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43f8/8068305/3e1ff12b9780/cancers-13-01777-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43f8/8068305/95ec15d31837/cancers-13-01777-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43f8/8068305/f9127b773c08/cancers-13-01777-g007.jpg

相似文献

1
SIO: A Spatioimageomics Pipeline to Identify Prognostic Biomarkers Associated with the Ovarian Tumor Microenvironment.SIO:一种用于识别与卵巢肿瘤微环境相关的预后生物标志物的空间影像组学流程。
Cancers (Basel). 2021 Apr 8;13(8):1777. doi: 10.3390/cancers13081777.
2
Spatial Transcriptomics Depict Ligand-Receptor Cross-talk Heterogeneity at the Tumor-Stroma Interface in Long-Term Ovarian Cancer Survivors.空间转录组学描绘了长期卵巢癌幸存者肿瘤-基质界面上配体-受体相互作用的异质性。
Cancer Res. 2023 May 2;83(9):1503-1516. doi: 10.1158/0008-5472.CAN-22-1821.
3
CXCL10 alters the tumour immune microenvironment and disease progression in a syngeneic murine model of high-grade serous ovarian cancer.CXCL10在高级别浆液性卵巢癌的同基因小鼠模型中改变肿瘤免疫微环境和疾病进展。
Gynecol Oncol. 2017 Jun;145(3):436-445. doi: 10.1016/j.ygyno.2017.03.007. Epub 2017 Mar 17.
4
WNT signaling inducing activity in ascites predicts poor outcome in ovarian cancer.腹水 WNT 信号诱导活性可预测卵巢癌不良预后。
Theranostics. 2020 Jan 1;10(2):537-552. doi: 10.7150/thno.37423. eCollection 2020.
5
Single-cell RNA-sequencing analysis reveals divergent transcriptome events between platinum-sensitive and platinum-resistant high-grade serous ovarian carcinoma.单细胞RNA测序分析揭示了铂敏感和铂耐药高级别浆液性卵巢癌之间不同的转录组事件。
J Gene Med. 2023 Oct;25(10):e3504. doi: 10.1002/jgm.3504. Epub 2023 Apr 26.
6
High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification.单细胞 RNA 测序细化的高级别浆液性卵巢癌:特定细胞亚型影响生存并决定分子亚型分类。
Genome Med. 2021 Jul 9;13(1):111. doi: 10.1186/s13073-021-00922-x.
7
CXCL13 shapes immunoactive tumor microenvironment and enhances the efficacy of PD-1 checkpoint blockade in high-grade serous ovarian cancer.CXCL13 塑造免疫活性肿瘤微环境,并增强 PD-1 检查点阻断在高级别浆液性卵巢癌中的疗效。
J Immunother Cancer. 2021 Jan;9(1). doi: 10.1136/jitc-2020-001136.
8
Phenotypic Characterization by Mass Cytometry of the Microenvironment in Ovarian Cancer and Impact of Tumor Dissociation Methods.通过质谱流式细胞术对卵巢癌微环境进行表型特征分析及肿瘤解离方法的影响
Cancers (Basel). 2021 Feb 11;13(4):755. doi: 10.3390/cancers13040755.
9
Novel protein and immune response markers of human serous tubal intraepithelial carcinoma of the ovary.人卵巢浆液性输卵管上皮内癌的新型蛋白和免疫反应标志物。
Cancer Biomark. 2019;26(4):471-479. doi: 10.3233/CBM-190528.
10
Machine learning-based integration develops an immune-related risk model for predicting prognosis of high-grade serous ovarian cancer and providing therapeutic strategies.基于机器学习的整合开发了一种免疫相关风险模型,用于预测高级别浆液性卵巢癌的预后,并提供治疗策略。
Front Immunol. 2023 Apr 5;14:1164408. doi: 10.3389/fimmu.2023.1164408. eCollection 2023.

引用本文的文献

1
CD103+CD56+ ILCs Are Associated with an Altered CD8+ T-cell Profile within the Tumor Microenvironment.CD103+CD56+固有淋巴细胞与肿瘤微环境中CD8+ T细胞谱的改变有关。
Cancer Immunol Res. 2025 Apr 2;13(4):527-546. doi: 10.1158/2326-6066.CIR-24-0151.
2
Unlocking ovarian cancer heterogeneity: advancing immunotherapy through single-cell transcriptomics.揭示卵巢癌异质性:通过单细胞转录组学推进免疫治疗
Front Oncol. 2024 May 30;14:1388663. doi: 10.3389/fonc.2024.1388663. eCollection 2024.
3
Spatial Dissection of the Immune Landscape of Solid Tumors to Advance Precision Medicine.

本文引用的文献

1
Imaging mass cytometry and multiplatform genomics define the phenogenomic landscape of breast cancer.成像质谱流式细胞术和多平台基因组学描绘了乳腺癌的表型基因组图谱。
Nat Cancer. 2020 Feb;1(2):163-175. doi: 10.1038/s43018-020-0026-6. Epub 2020 Feb 17.
2
Tumor-associated macrophages promote ovarian cancer cell migration by secreting transforming growth factor beta induced (TGFBI) and tenascin C.肿瘤相关巨噬细胞通过分泌转化生长因子β诱导(TGFBI)和 tenascin C 促进卵巢癌细胞迁移。
Cell Death Dis. 2020 Apr 20;11(4):249. doi: 10.1038/s41419-020-2438-8.
3
CD73 on cancer-associated fibroblasts enhanced by the A-mediated feedforward circuit enforces an immune checkpoint.
实体瘤免疫景观的空间解析以推进精准医学。
Cancer Immunol Res. 2024 Jul 2;12(7):800-813. doi: 10.1158/2326-6066.CIR-23-0699.
4
Spatiotemporal architecture of immune cells and cancer-associated fibroblasts in high-grade serous ovarian carcinoma.高级别浆液性卵巢癌中免疫细胞和癌相关成纤维细胞的时空结构。
Sci Adv. 2024 Apr 19;10(16):eadk8805. doi: 10.1126/sciadv.adk8805. Epub 2024 Apr 17.
5
Molecular, Metabolic, and Subcellular Mapping of the Tumor Immune Microenvironment via 3D Targeted and Non-Targeted Multiplex Multi-Omics Analyses.通过3D靶向和非靶向多重多组学分析对肿瘤免疫微环境进行分子、代谢和亚细胞图谱绘制。
Cancers (Basel). 2024 Feb 20;16(5):846. doi: 10.3390/cancers16050846.
6
Targeting the immune microenvironment for ovarian cancer therapy.针对卵巢癌治疗的免疫微环境。
Front Immunol. 2023 Dec 18;14:1328651. doi: 10.3389/fimmu.2023.1328651. eCollection 2023.
7
Role of epithelial-mesenchymal transition factor SNAI1 and its targets in ovarian cancer aggressiveness.上皮-间质转化因子SNAI1及其靶点在卵巢癌侵袭性中的作用
J Cancer Metastasis Treat. 2023;9. doi: 10.20517/2394-4722.2023.34. Epub 2023 Jun 30.
8
Novel insights from spatial transcriptome analysis in solid tumors.实体瘤空间转录组分析的新见解。
Int J Biol Sci. 2023 Sep 4;19(15):4778-4792. doi: 10.7150/ijbs.83098. eCollection 2023.
9
Spatial Transcriptomics Depict Ligand-Receptor Cross-talk Heterogeneity at the Tumor-Stroma Interface in Long-Term Ovarian Cancer Survivors.空间转录组学描绘了长期卵巢癌幸存者肿瘤-基质界面上配体-受体相互作用的异质性。
Cancer Res. 2023 May 2;83(9):1503-1516. doi: 10.1158/0008-5472.CAN-22-1821.
10
Tumor-Infiltrating Lymphocytes (TILs) in Epithelial Ovarian Cancer: Heterogeneity, Prognostic Impact, and Relationship with Immune Checkpoints.上皮性卵巢癌中的肿瘤浸润淋巴细胞(TILs):异质性、预后影响及与免疫检查点的关系
Cancers (Basel). 2022 Oct 29;14(21):5332. doi: 10.3390/cancers14215332.
肿瘤相关成纤维细胞中的 CD73 受 A 介导的正反馈回路增强,从而加强了免疫检查点。
Nat Commun. 2020 Jan 24;11(1):515. doi: 10.1038/s41467-019-14060-x.
4
The single-cell pathology landscape of breast cancer.乳腺癌的单细胞病理学图谱。
Nature. 2020 Feb;578(7796):615-620. doi: 10.1038/s41586-019-1876-x. Epub 2020 Jan 20.
5
Cancer statistics, 2020.癌症统计数据,2020 年。
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.
6
TSPAN9 suppresses the chemosensitivity of gastric cancer to 5-fluorouracil by promoting autophagy.四跨膜蛋白9通过促进自噬抑制胃癌对5-氟尿嘧啶的化疗敏感性。
Cancer Cell Int. 2020 Jan 3;20:4. doi: 10.1186/s12935-019-1089-2. eCollection 2020.
7
Protease activated receptor 2 mediates tryptase-induced cell migration through MYO10 in colorectal cancer.蛋白酶激活受体2通过MYO10介导类胰蛋白酶诱导的结直肠癌细胞迁移。
Am J Cancer Res. 2019 Sep 1;9(9):1995-2006. eCollection 2019.
8
High expression of bone morphogenetic protein (BMP) 6 and BMP7 are associated with higher immune cell infiltration and better survival in estrogen receptor‑positive breast cancer.骨形态发生蛋白(BMP)6和BMP7的高表达与雌激素受体阳性乳腺癌中更高的免疫细胞浸润及更好的生存率相关。
Oncol Rep. 2019 Oct;42(4):1413-1421. doi: 10.3892/or.2019.7275. Epub 2019 Aug 12.
9
Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy.癌症相关成纤维细胞:抗肿瘤免疫治疗的一个新兴靶点。
J Hematol Oncol. 2019 Aug 28;12(1):86. doi: 10.1186/s13045-019-0770-1.
10
Chemotherapy Resistance in Advanced Ovarian Cancer Patients.晚期卵巢癌患者的化疗耐药性
Biomark Cancer. 2019 Jul 5;11:1179299X19860815. doi: 10.1177/1179299X19860815. eCollection 2019.